ArticleScientific reports2025
High-fidelity in silico generation and augmentation of TCR repertoire data using generative adversarial networks.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- DTCR: generating realistic, diverse, and epitope-specific T cell receptor sequences via a discrete diffusion model.Briefings in bioinformatics · 2026Article
- AI-driven computational methods and benchmarking for T-cell antigen identification.Briefings in bioinformatics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Engineered T-cell receptor (eTCR) systems rely on accurately generated T-cell receptor (TCR) sequences to enhance immunotherapy predictability and efficacy. The most variable and crucial part of the TCR receptor is the CDR3 sequence region. Current methods for generating CDR3 sequences, including motif-based and Markov models, struggle to generate reliable, diverse, and novel TCR sequences. In this study, we present the first application of Generative Adversarial Networks (GANs) for producing biologically reliable CDR3 sequences, using Long Short-Term Memory (LSTM) networks and LeakyReLU-based GANs. Our results show that LSTM models generate more diverse sequences with higher accuracy, lower discriminator loss, and higher AUC compared to LeakyReLU. However, LeakyReLU provides greater stability with a lower generator loss, achieving a total Pearson correlation score of over 0.9. Both models demonstrate the ability to produce highly realistic TCR sequences, as validated by t-SNE clustering, frequency distribution analysis, TCRd3 BLAST analysis, and in silico docking. These findings highlight the potential of GANs as a powerful tool for generating synthetic yet biologically relevant TCR sequences, a crucial step toward improving eTCR-based therapies. Further refinement of amino acid frequency distributions and clinical validation will enhance their applicability for therapeutic purposes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.